Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Frontiers in Pediatrics|June 30, 2023
Corrigendum: Mineral bone disorder in children with chronic kidney disease: data from the KNOW-Ped CKD (Korean cohort study for outcome in patients with pediatric chronic kidney disease) studyJiwon Jung, Keum Hwa Lee, Eujin Park, et al.
Frontiers in Pediatrics|March 6, 2023
Mineral bone disorder in children with chronic kidney disease: Data from the KNOW-Ped CKD (Korean cohort study for outcome in patients with pediatric chronic kidney disease) studyJiwon Jung, Keum Hwa Lee, Eujin Park, et al.
Oncogene|November 5, 2020
The hidden role of paxillin: localization to nucleus promotes tumor angiogenesisKyunghee Noh, Duc-Hiep Bach, Hyun-Jin Choi, et al.
Pediatric Nephrology (Berlin, Germany)|April 2, 2020
Dyslipidemia in pediatric CKD patients: results from KNOW-PedCKD (KoreaN cohort study for Outcomes in patients With Pediatric CKD)Hee Sun Baek, Seong Heon Kim, Hee Gyung Kang, et al.
Pediatric Nephrology (Berlin, Germany)|July 8, 2017
Health-related quality of life of children with pre-dialysis chronic kidney diseaseHee Sun Baek, Hee Gyung Kang, Hyun Jin Choi, et al.
BMC Nephrology|March 26, 2016
KNOW-Ped CKD (KoreaN cohort study for outcomes in patients with pediatric CKD): Design and methodsHee Gyung Kang, Hyun Jin Choi, Kyung Hee Han, et al.
Journal of Clinical Medicine|January 18, 2020
Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-Positive Recurrent Cervical CancerChel Hun Choi, Hyun Jin Choi, Jeong-Won Lee, et al.
Pediatric Nephrology (Berlin, Germany)|March 12, 2022
Baseline characteristics of participants enrolled in the KoreaN cohort study for Outcomes in patients With Pediatric Chronic Kidney Disease (KNOW-Ped CKD)Peong Gang Park, Hee Gyung Kang, Eujin Park, et al.
Pediatric Nephrology (Berlin, Germany)|June 22, 2019
Mental health and psychosocial adjustment in pediatric chronic kidney disease derived from the KNOW-Ped CKD studyNa Ri Kang, Yo Han Ahn, Eujin Park, et al.
Medicine|November 16, 2018
Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome: A multicenter open-label trial in KoreaYo Han Ahn, Seong Heon Kim, Kyoung Hee Han, et al.
Pageof 18